RT Journal Article
SR Electronic
A1 Gordon, Debra
T1 Reduced CV Risk with Use of MTX and TNF-α Inhibitors in Patients with RA
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 13
SP 13
OP 14
DO 10.1177/155989771113006
UL http://mdc.sagepub.com/content/11/13/13.2.abstract
AB Patients with rheumatoid arthritis who did not have preexisting coronary artery disease and used methotrexate (MTX) for at least 24 months or a tumor necrosis factor (TNF) antagonist for at least 40 months were significantly less likely to develop cardiovascular disease than those who did not use MTX or anti -TNF therapy.